| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
26,320,000 |
| Market
Cap: |
3.83(M) |
| Last
Volume: |
169,426 |
Avg
Vol: |
168,966 |
| 52
Week Range: |
$0.1454 - $0.1454 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. Co. is developing multiple precision-targeted products based on its Manocept™ platform to improve patient care by identifying the sites and pathways of undetected disease and enable diagnostic, clinical decision-making and targeted treatment. Co.'s business is focused on two primary types of drug products: diagnostic substances, including Tc99m tilmanocept and other diagnostic applications of its Manocept platform; and therapeutic development programs, including therapeutic applications of its Manocept platform.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Platinum Partners Value Arbitrage Fund, Lp |
10% Owner |
– – • |
2012-09-04 |
4 |
S |
$3.80 |
$780,980 |
D/D |
(205,521) |
7,266,847 |
|
- |
|
| Platinum Partners Value Arbitrage Fund, Lp |
10% Owner |
– – • |
2012-08-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,472,368 |
|
- |
|
| Troup Gordon A |
Director |
• • – |
2012-08-15 |
4 |
B |
$3.58 |
$17,895 |
D/D |
5,000 |
72,000 |
2.81 |
- |
|
| Larson Brent L |
SVP, CFO, Treas & Secy |
• – – |
2012-04-20 |
4 |
D |
$2.69 |
$40,350 |
D/D |
(15,000) |
200,125 |
|
- |
|
| Brown Rodger A |
Vice President |
• – – |
2012-04-20 |
4 |
D |
$2.69 |
$40,350 |
D/D |
(15,000) |
94,221 |
|
- |
|
| Tulip Thomas H. |
EVP & Chief Business officer |
– – – |
2012-04-20 |
4 |
D |
$2.69 |
$20,175 |
D/D |
(7,500) |
12,500 |
|
- |
|
| Troup Gordon A |
Director |
– • – |
2012-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
67,000 |
|
- |
|
| Jones Jess |
Director |
– • – |
2012-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
17,000 |
|
- |
|
| Rowinsky Eric K |
Director |
– • – |
2012-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
62,000 |
|
- |
|
| Drake Peter F |
Director |
– • – |
2012-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
27,000 |
|
- |
|
| Ford Brendan A |
Director |
– • – |
2012-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
67,000 |
|
- |
|
| Pykett Mark Jerome |
Pres. & CEO |
• • – |
2012-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
303,300 |
|
- |
|
| Bupp David C |
Director |
– • – |
2011-12-19 |
4 |
AS |
$2.54 |
$19,848 |
D/D |
(7,814) |
2,750,328 |
|
- |
|
| Bupp David C |
Director |
– • – |
2011-12-16 |
4 |
AS |
$2.45 |
$103,356 |
D/D |
(42,186) |
2,758,142 |
|
- |
|
| Tulip Thomas H. |
EVP & Chief Business officer |
– – – |
2011-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
|
- |
|
| Rowinsky Eric K |
Director |
– • – |
2011-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
45,000 |
|
- |
|
| Bupp David C |
Director |
– • – |
2011-11-21 |
4 |
AS |
$2.19 |
$21,900 |
D/D |
(10,000) |
2,500,328 |
|
- |
|
| Bupp David C |
Director |
– • – |
2011-11-18 |
4 |
AS |
$2.25 |
$13,725 |
D/D |
(6,100) |
2,510,328 |
|
- |
|
| Bupp David C |
Director |
– • – |
2011-11-17 |
4 |
AS |
$2.27 |
$22,700 |
D/D |
(10,000) |
2,516,428 |
|
- |
|
| Bupp David C |
Director |
– • – |
2011-10-17 |
4 |
AS |
$2.89 |
$144,500 |
D/D |
(50,000) |
2,550,328 |
|
- |
|
| Drake Peter F |
Director |
– • – |
2011-09-15 |
4 |
B |
$3.08 |
$30,780 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| Pykett Mark Jerome |
Pres. & CEO |
• • – |
2011-08-22 |
4 |
B |
$2.56 |
$2,816 |
I/I |
1,100 |
1,100 |
2.58 |
- |
|
| Pykett Mark Jerome |
Pres. & CEO |
• • – |
2011-08-22 |
4 |
B |
$2.56 |
$8,603 |
D/D |
3,300 |
3,300 |
2.81 |
- |
|
| Troup Gordon A |
Director |
– • – |
2011-08-22 |
4 |
B |
$2.61 |
$26,100 |
D/D |
10,000 |
50,000 |
2.39 |
- |
|
| Ford Brendan A |
Director |
– • – |
2011-08-19 |
4 |
B |
$2.51 |
$50,200 |
D/D |
20,000 |
50,000 |
2.39 |
- |
|
411 Records found
|
|
Page 11 of 17 |
|
|
